Every day, we sift through the filings to spot where the real conviction lies โ cutting through the noise to highlight the most meaningful insider moves.
๐ Ares Management $ARES โ Ashish Bhutani purchased $1.27 million via Form 4.
Buyers showing up near support is exactly what you want to see in a name trying to repair its damage after a sharp drawdown.
๐ Globe Life $GL โ Director Mark Blinn bought $153,540 per Form 4.
Smaller in size, but notable insider support as this life insurer presses toward fresh highs.
Hereโs The Hot Corner, with data from February 10, 2026:
๐ Incyte $INCY โ Baker Bros. increased their stake from 15.50% to 15.70%.
One of biotechโs most respected specialist investors adding again to a core position. Itโs incremental, but when long-term operators press their winners, we pay attention.
๐ Ocular Therapeutix $OCUL โ Deep Track Capital raised its stake from 4.20% to 5.13%.
Crosses the five percent threshold in a speculative biotech carving out a massive base.
